title: The evaluation of QT intervals during diagnosis and after follow-up in acromegaly patients.
abstract: BACKGROUND
  It was aimed to calculate QT intervals in patients with acromegaly and to reveal its correlation between QT intervals, and growth hormone and insulin like growth factor-1.
  
  
  METHODS
  Forty-one patients with acromegaly were enrolled into the study. Another 41 individuals with similar features, such as comorbid diseases, age and sex constituted the control group. The electrocardiographies of patients with acromegaly were evaluated at the baseline and after the follow-up. Only one electrocardiography was performed for controls. QT maximum, QT minimum, QT dispersion, corrected QT maximum, corrected QT minimum and corrected QT dispersion were calculated.
  
  
  RESULTS
  Baseline QT maximum, QT dispersion, corrected QT maximum and corrected QT dispersion were significantly longer than the values of controls. Corrected QT maximum and corrected QT dispersion were significantly shorter after the follow-up, compared to the baseline in patients. QT maximum, QT dispersion, corrected QT maximum and corrected QT dispersion after the follow-up were not statistically different from the values of controls. Except the negative correlation between growth hormone and corrected QT dispersion in patients after the follow-up, no other correlation was detected between QT values and growth hormone or insulin like growth factor-1 levels. Corrected QT dispersion was found to be related with the disease duration in patients.
  
  
  CONCLUSIONS
  For acromegaly patients, it is important to detect clinical predictors of cardiac arrhytmias. QT dispersion is considered a beneficial predictor for ventricular arrhytmias. When compared to controls, prolonged QT intervals were determined in our acromegalic patients.
  
  
  CONCLUSIONS
  We consider that QT intervals may also be utilized in the evaluation of increased cardiovascular risk in patients with acromegaly.
authors.affiliation: Department of Endocrinology and Metabolism. Ataturk Education and Research Hospital. Ankara. Turkey.
authors.forename: Husniye
authors.initials: H
authors.lastname: Baser
authors.affiliation: Department of Cardiology. Ataturk Education and Research Hospital. Ankara. Turkey.
authors.forename: Nihal
authors.initials: N
authors.lastname: Akar Bayram
authors.affiliation: Department of Endocrinology and Metabolism. Ataturk Education and Research Hospital. Ankara. Turkey.
authors.forename: Burcak
authors.initials: B
authors.lastname: Polat
authors.affiliation: Department of Endocrinology and Metabolism. Ataturk Education and Research Hospital. Ankara. Turkey.
authors.forename: Berna
authors.initials: B
authors.lastname: Evranos
authors.affiliation: Department of Endocrinology and Metabolism. Ataturk Education and Research Hospital. Ankara. Turkey.
authors.forename: Reyhan
authors.initials: R
authors.lastname: Ersoy
authors.affiliation: Department of Cardiology. Ataturk Education and Research Hospital. Ankara. Turkey.
authors.forename: Engin
authors.initials: E
authors.lastname: Bozkurt
authors.affiliation: Department of Endocrinology and Metabolism. Ataturk Education and Research Hospital. Ankara. Turkey.
authors.forename: Bekir
authors.initials: B
authors.lastname: Cakir
mesh_terms: D000172:Acromegaly / Q000097:blood / Q000150:complications*; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000097:blood / Q000150:complications* / Q000175:diagnosis*; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008297:Male
chemical_list: D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone